Abraham Morgentaler

Abraham Morgentaler, MD, FACS is a pioneering figure in the field of men's health and urology. Here are some key points about his background and accomplishments:

Professional Background

Dr. Morgentaler is the Founder and Director of Men's Health Boston, which he established in 1999 as the first comprehensive men's health center in the United States.14 He is also an Associate Clinical Professor of Urology at Harvard Medical School and Beth Israel Deaconess Medical Center.15

Expertise and Contributions

Dr. Morgentaler is internationally recognized as a leading expert in:

• Men's sexual and reproductive health
• Testosterone therapy
• Prostate health

His research has revolutionized understanding of testosterone's effects on men's health, particularly challenging long-held beliefs about testosterone and prostate cancer.26 Some of his major contributions include:

• Pioneering modern use of testosterone therapy
• Developing the "Saturation Model" for understanding testosterone's relationship to prostate cancer
• Demonstrating that testosterone therapy does not increase prostate cancer risk

Publications and Recognition

Dr. Morgentaler has:

• Published over 200 scientific articles
• Authored four books for the public on men's health topics
• Lectured in more than 30 countries
• Appeared on numerous national TV and radio shows

He has received several honors, including the 2022 John K. Lattimer Lecture at the American Urological Association annual meeting.3

Leadership Roles

Dr. Morgentaler has played key leadership roles in advancing the field of men's health:

• Co-founder and first President of the Androgen Society
• Co-founder of the Androgen Study Group
• Senior Editor of the journal "Androgens: Clinical Research and Therapeutics"

Through his clinical practice, research, and advocacy, Dr. Abraham Morgentaler has been instrumental in elevating men's health as a crucial medical specialty and transforming approaches to testosterone therapy and men's sexual health care.